Nuvectis Pharma (NVCT) has a market capitalization of $151.7M, based on 25.46M shares at a price of $5.96 (down 0.3% on Friday).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
October 2025 | $5.96 | 573,857 | 25,456,848 | $151,722,814.08 |
September 2025 | $6.02 | 1,918,100 | 21,366,300 | $128,625,126.00 |
August 2025 | $6.56 | 2,261,800 | 21,366,300 | $140,162,928.00 |
July 2025 | $6.96 | 4,141,400 | 21,366,300 | $148,709,448.00 |
June 2025 | $7.47 | 3,811,800 | 21,366,300 | $159,606,261.00 |
May 2025 | $9.41 | 2,748,200 | 21,366,300 | $201,056,883.00 |
April 2025 | $9.96 | 3,117,400 | 21,366,300 | $212,808,348.00 |
March 2025 | $9.77 | 2,682,700 | 19,937,500 | $194,789,375.00 |
February 2025 | $6.69 | 2,526,700 | 19,937,500 | $133,381,875.00 |
January 2025 | $6.76 | 1,947,867 | 19,937,500 | $134,777,500.00 |
December 2024 | $5.41 | 1,993,174 | 17,113,200 | $92,582,412.00 |
November 2024 | $5.04 | 5,868,233 | 17,113,200 | $86,250,528.00 |
October 2024 | $7.47 | 3,312,406 | 17,113,200 | $127,835,604.00 |
September 2024 | $6.29 | 1,807,611 | 17,230,600 | $108,380,474.00 |
August 2024 | $6.96 | 2,374,446 | 17,230,600 | $119,924,976.00 |
July 2024 | $6.35 | 1,122,609 | 17,230,600 | $109,414,310.00 |
June 2024 | $6.33 | 2,436,084 | 16,900,600 | $106,980,798.00 |
May 2024 | $6.77 | 2,327,591 | 16,900,600 | $114,417,062.00 |
April 2024 | $6.08 | 1,452,522 | 16,900,600 | $102,755,648.00 |
March 2024 | $8.20 | 2,389,755 | 16,559,300 | $135,786,260.00 |
February 2024 | $9.87 | 2,146,500 | 16,559,300 | $163,440,291.00 |
January 2024 | $7.29 | 2,124,200 | 16,559,300 | $120,717,297.00 |
December 2023 | $8.34 | 1,165,900 | 17,418,900 | $145,273,626.00 |
November 2023 | $8.50 | 717,600 | 17,418,900 | $148,060,650.00 |
October 2023 | $8.95 | 950,700 | 17,418,900 | $155,899,155.00 |
